​
​

Renovaro Biosciences Ownership | Who Owns Renovaro Biosciences?

OverviewRevenueFinancialsChart

Renovaro Biosciences Ownership Summary

Renovaro Biosciences is owned by 11.01% institutional investors, and 88.99% retail investors. Marshall wace, llp is the largest institutional shareholder, holding 0% of ENOB shares.

ENOB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRenovaro Biosciences11.01%-88.99%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Marshall wace, llp---
Exoduspoint capital management, lp---
Lazard asset management---
Susquehanna group, llp---
Sg americas securities---
Millennium management---
Man group---
Brevan howard capital management lp---
Squarepoint ops---
Balyasny asset management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Marshall wace, llp---
Exoduspoint capital management, lp---
Lazard asset management---
Susquehanna group, llp---
Sg americas securities---
Millennium management---
Man group---
Brevan howard capital management lp---
Squarepoint ops---
Balyasny asset management---

Top Buyers

HolderShares% AssetsChange
Point72 asia (singapore) pte.---1.86K
Lazard asset management---2.51K
Macquarie group---5.07K
Polymer capital management (hk)---11.80K
Susquehanna group, llp---12.50K

Top Sellers

HolderShares% AssetsChange
Millennium management---293.63K
Man group---107.90K
Laurion capital management lp---61.48K
Exoduspoint capital management, lp---58.78K
Qube research---43.92K

Sold Out

HolderChange
Point72 asia (singapore) pte.-1.86K
Lazard asset management-2.51K
Macquarie group-5.07K
Polymer capital management (hk)-11.80K
Susquehanna group, llp-12.50K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20244319.44%7,250,533181.83%1172.14%29-3.33%8100.00%
Dec 31, 20233656.52%2,572,67372.87%376.49%30172.73%4-33.33%
Sep 30, 202323-25.81%1,488,192-19.54%220.91%11-6-68.42%
Jun 30, 202331-22.50%1,849,529-44.03%39.43%11-47.62%1946.15%
Mar 31, 202340-6.98%3,304,548-9.02%513.79%2116.67%138.33%

Recent Insider Transactions

DateNameRoleActivityValue
May 18, 2022Gumrukcu Serhat Sell$1.00M
May 18, 2022Sindlev Rene Buy$1.00M
May 18, 2022Sindlev Rene Buy$1.03M
Mar 22, 2022Sandler Carl Forest Sell$17.46K
Feb 18, 2022Sandler Carl Forest Sell$61.35K

Insider Transactions Trends

DateBuySell
2023 Q3--
2023 Q2--
2023 Q1--
2022 Q4--
2022 Q3--

ENOB Ownership FAQ

Who Owns Renovaro Biosciences?

Renovaro Biosciences shareholders are primarily institutional investors at 11.01%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Renovaro Biosciences's industry, Biotech Stocks , is 44.97%, which Renovaro Biosciences falls below.

Who owns the most shares of Renovaro Biosciences?

Renovaro Biosciences’s largest shareholders are Marshall wace, llp (0 shares, 0%), Exoduspoint capital management, lp (0 shares, 0%), and Lazard asset management (0 shares, 0%). Together, they hold 0% of Renovaro Biosciences’s total shares outstanding.

Does Blackrock own Renovaro Biosciences?

BlackRock is not among the top 10 institutional shareholders of Renovaro Biosciences.

Who is Renovaro Biosciences’s biggest shareholder by percentage of total assets invested?

Marshall wace, llp is Renovaro Biosciences’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Renovaro Biosciences shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools